- Home
- AQST vs QNST Comparison
AQST vs QNST Comparison
Compare AQST & QNST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AQST | QNST |
|---|---|---|
| Founded | 2004 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 809.3M | 792.3M |
| IPO Year | 2018 | 2010 |
Fundamental Metrics
Financial Performance| Metric | AQST | QNST |
|---|---|---|
| Price | $5.93 | $13.81 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 5 |
| Target Price | $10.00 | ★ $26.40 |
| AVG Volume (30 Days) | ★ 2.9M | 559.4K |
| Earning Date | 11-05-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.18 |
| Revenue | $43,397,000.00 | ★ $1,100,345,000.00 |
| Revenue This Year | N/A | $11.18 |
| Revenue Next Year | $51.39 | $9.54 |
| P/E Ratio | ★ N/A | $77.56 |
| Revenue Growth | N/A | ★ 43.12 |
| 52 Week Low | $2.12 | $12.98 |
| 52 Week High | $7.55 | $25.50 |
Technical Indicators
Market Signals| Indicator | AQST | QNST |
|---|---|---|
| Relative Strength Index (RSI) | 48.68 | 45.53 |
| Support Level | $5.73 | $12.98 |
| Resistance Level | $6.40 | $14.12 |
| Average True Range (ATR) | 0.35 | 0.40 |
| MACD | 0.05 | 0.06 |
| Stochastic Oscillator | 63.03 | 52.53 |
Price Performance
Historical ComparisonAbout AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.
About QNST QuinStreet Inc.
QuinStreet Inc focuses on marketplaces and technologies for the financial services and home services industries. It delivers measurable and cost-effective marketing results to its clients, in the form of qualified inquiries such as clicks, leads, calls, applications, or customers. It generates revenue by delivering measurable online marketing results to the clients. Its products and services are Customer Acquisition, QuinStreet Rating Platform (QRP), and CloudControlMedia. Geographically, it operates in United States and Internationally, of which maximum revenue is derived from United States.